Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect and Safety of Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Patients With Non-small Cell Lung Cancer

NCT07041320 is registered in ClinicalTrials.gov with Anhui Chest Hospital as lead sponsor.

NCT NCT07041320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07041320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect and Safety of Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Patients With Non-small Cell Lung Cancer
Lead sponsor
Anhui Chest Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 15, 2023
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly (people aged 65 or more), lung cancer (nsclc)